Rossari Biotech Ltd

Rossari Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 08 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 January 2026, providing investors with the latest insights into its performance and outlook.

Rossari Biotech Ltd, a player in the specialty chemicals sector, has recorded a new all-time low of Rs.519.4, marking a significant milestone in its ongoing share price decline. The stock’s performance over recent periods highlights a sustained downward trajectory, reflecting a challenging market environment and company-specific factors.

Rossari Biotech Ltd’s stock touched a new 52-week and all-time low of Rs.519.4 today, marking a significant decline amid a backdrop of sustained underperformance relative to market benchmarks and sector peers.

Rossari Biotech Ltd, a player in the Specialty Chemicals sector, has reached a new all-time low of Rs.526.05, marking a significant milestone in its ongoing decline. The stock’s performance continues to lag behind key benchmarks, reflecting a challenging period for the company amid broader market pressures.

Rossari Biotech Ltd’s shares touched a new 52-week low of Rs.528.1 on 19 Jan 2026, marking a significant decline amid a sustained downtrend. The stock has underperformed its sector and benchmark indices, reflecting ongoing pressures within the specialty chemicals segment.

Rossari Biotech Ltd’s stock price declined to a fresh 52-week low of Rs.541.9 today, marking a significant milestone in its recent downward trajectory. The stock has underperformed its sector and benchmark indices, reflecting ongoing challenges in maintaining momentum within the Specialty Chemicals industry.

Rossari Biotech Ltd’s shares declined to a fresh 52-week low of Rs.550.1 on 9 Jan 2026, marking a significant downturn for the specialty chemicals company amid a sustained period of underperformance relative to the broader market.

Rossari Biotech Ltd is rated Sell by MarketsMOJO. This rating was last updated on 08 December 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 05 January 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.

Rossari Biotech Ltd is rated Sell by MarketsMOJO. This rating was last updated on 08 Dec 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 25 December 2025, providing investors with the latest insights into the company’s performance and outlook.

Rossari Biotech has reached a new 52-week low of Rs.563.65, marking a significant point in its recent trading performance as the stock continues to trade below all major moving averages amid a sustained period of decline.

Rossari Biotech's stock has reached a fresh 52-week low, closing just 0.45% above its lowest price in the past year at Rs 566. The stock has been on a declining trajectory over the last three trading sessions, reflecting ongoing pressures within the specialty chemicals sector.

Rossari Biotech's stock price reached a fresh 52-week low of Rs.566 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and benchmark indices, reflecting ongoing pressures within the specialty chemicals segment.

Rossari Biotech, a key player in the Specialty Chemicals sector, has experienced a notable shift in market evaluation following recent developments across technical indicators, financial trends, valuation metrics, and overall quality parameters. This article analyses the factors influencing the revised market perspective on the company amid a challenging performance backdrop.

Rossari Biotech, a key player in the Specialty Chemicals sector, is currently exhibiting a shift in its technical momentum, with multiple indicators signalling a bearish trend across weekly and monthly timeframes. This article analyses the recent changes in technical parameters including MACD, RSI, moving averages, and other momentum oscillators to provide a comprehensive view of the stock’s current market stance.

Rossari Biotech, a key player in the Specialty Chemicals sector, has experienced a revision in its market assessment following a detailed review of its financial performance, valuation metrics, technical indicators, and overall quality parameters. This article explores the factors influencing the recent changes in the company’s evaluation, providing investors with a comprehensive understanding of its current standing.

Rossari Biotech, a key player in the specialty chemicals sector, has exhibited a nuanced shift in its technical momentum, reflecting a complex interplay of market forces and indicator signals. Recent data reveals a transition from a bearish technical trend to a mildly bearish stance, underscoring a period of consolidation and cautious investor sentiment.